ABEONA THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.4 USD | -4.35% |
|
+4.76% | -12.18% |
| 05-16 | Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating | MT |
| 05-15 | Transcript : Abeona Therapeutics Inc., Q1 2024 Earnings Call, May 15, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABEONA THERAPEUTICS INC. | Other Biotechnology & Medical Research | -4.35% | +4.76% | -12.18% | +47.16% | -97.63% | 174M |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- ABEO Stock
- Charts Abeona Therapeutics Inc.
- Comparison Chart
